HBK Investments’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-25,200
Closed -$262K 732
2021
Q3
$262K Sell
25,200
-124,800
-83% -$1.09M ﹤0.01% 578
2021
Q2
$1.57M Buy
+150,000
New +$1.48M 0.01% 536
2021
Q1
Sell
-611,598
Closed -$6.78M 844
2020
Q4
$6.78M Sell
611,598
-138,402
-18% -$1.41M 0.04% 204
2020
Q3
$7.54M Hold
750,000
0.06% 157
2020
Q2
$7.48M Buy
+750,000
New +$7.37M 0.1% 125
2020
Q1
Sell
-750,000
Closed -$7.37M 90
2019
Q4
$7.37M Buy
+750,000
New +$7.34M 0.07% 170

Other funds holding SRTA

HBK Investments's SRTA Position: Q4 2021 in Review

HBK Investments sold out of Strata Critical Medical Inc (SRTA) in Q4 2021, closing a stake of 25,200 shares — an estimated $262K sold.

HBK Investments first reported a position in SRTA in Q4 2019 and held it in 6 quarters. The position peaked at $7.54M in Q3 2020. 79 funds tracked by Wall St. Rank hold SRTA as of Q4 2021.

  • HBK Investments reported no remaining Strata Critical Medical Inc position as of Q4 2021 after selling out during the quarter.
  • HBK Investments sold 25,200 Strata Critical Medical Inc shares in Q4 2021, an estimated $262K.
  • HBK Investments first reported a position in Strata Critical Medical Inc in Q4 2019 and held it in 6 quarters.
  • HBK Investments's Strata Critical Medical Inc position peaked at $7.54M in Q3 2020.
  • 79 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2021.

Based on HBK Investments's 13F filing for Q4 2021, filed 14 Feb 2022.